BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,485,393 | -2.8% | 607,037 | +22.4% | 1.48% | +7.7% |
Q2 2023 | $31,350,550 | +59.0% | 496,053 | +13.2% | 1.37% | +45.0% |
Q1 2023 | $19,716,823 | +15.1% | 438,249 | +12.0% | 0.95% | +14.3% |
Q4 2022 | $17,136,544 | -18.4% | 391,156 | +22.8% | 0.83% | -23.5% |
Q3 2022 | $20,991,000 | +15.5% | 318,574 | +87.8% | 1.08% | +61.4% |
Q4 2021 | $18,172,000 | -24.3% | 169,659 | -27.3% | 0.67% | -23.1% |
Q3 2021 | $24,007,000 | +20.6% | 233,508 | +3.2% | 0.87% | +20.3% |
Q2 2021 | $19,908,000 | -21.3% | 226,335 | -13.0% | 0.72% | -20.6% |
Q1 2021 | $25,293,000 | -24.3% | 260,134 | -12.7% | 0.91% | -17.7% |
Q4 2020 | $33,410,000 | -5.3% | 297,905 | -21.7% | 1.11% | -23.6% |
Q3 2020 | $35,281,000 | +14.4% | 380,589 | -3.8% | 1.45% | +8.0% |
Q2 2020 | $30,848,000 | +26.8% | 395,485 | -5.0% | 1.34% | -4.5% |
Q1 2020 | $24,337,000 | – | 416,166 | – | 1.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |